[Causes of the heart-circulatory changes in experimental fat embolism and their therapeutic consequences].
D000818:Animals; D001158:Arteries / Q000503:physiopathology; D001794:Blood Pressure; D002319:Cardiovascular System / Q000503:physiopathology*; D002415:Cats; D003331:Coronary Vessels / Q000503:physiopathology; D004176:Dipyridamole / Q000627:therapeutic use; D004562:Electrocardiography; D004620:Embolism, Fat / Q000188:drug therapy / Q000503:physiopathology*; D004877:Ergoloid Mesylates / Q000627:therapeutic use; D009638:Norepinephrine / Q000627:therapeutic use; D010713:Phosphatidylcholines / Q000627:therapeutic use; D011299:Prenylamine / Q000627:therapeutic use; D012110:Reserpine / Q000627:therapeutic use; D013328:Strophanthins / Q000627:therapeutic use; D013806:Theophylline / Q000627:therapeutic use; D014680:Veins / Q000503:physiopathology
D010713:Phosphatidylcholines; D013328:Strophanthins; D004176:Dipyridamole; D004877:Ergoloid Mesylates; D012110:Reserpine; D013806:Theophylline; D011299:Prenylamine; D009638:Norepinephrine
Ursachen der Herz-Kreislauf-Veränderungen bei experimenteller Fettembolie und ihre therapeutischen Konsequenzen.